Q4 2020 Holdings
Filed 2021-02-16 | 139 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $476.9M | 6,706,268 | 38.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $129.9M | 3,109,224 | 10.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $104.6M | 3,158,566 | 8.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $82.2M | 1,070,814 | 6.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $81.2M | 4,671,836 | 6.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $53.5M | 904,854 | 4.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $51.6M | 3,659,381 | 4.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $49.9M | 1,047,404 | 4.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $43.1M | 6,285,458 | 3.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $41.2M | 2,058,068 | 3.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $35.8M | 3,188,750 | 2.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $32.3M | 16,584,802 | 2.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $28.9M | 1,143,790 | 2.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $16.9M | 2,577,043 | 1.3% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $7.4M | 1,385,720 | 0.6% |
| Anavex Life Sciences Corp(AVXL) | COM NEW | 032797300 | $4.2M | 780,007 | 0.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $2.2M | 400,000 | 0.2% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $811.2K | 3,693,516 | 0.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $805.0K | 20,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $579.8K | 25,112,048 | 0.0% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $442.5K | $45,000,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $425.3K | 9,166,304 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $304.6K | 7,284,466 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $303.0K | 4,177,721 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $245.8K | 5,674,711 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $225.6K | 3,084,042 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $203.3K | 4,300,999 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $186.3K | 3,396,867 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $182.0K | 1,899,215 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $173.3K | $17,500,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $169.2K | 977,565 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $165.4K | $9,000,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $161.9K | 2,847,822 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $151.4K | 55,042,465 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $149.7K | 13,532,467 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $116.3K | 1,043,000 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $114.9K | 3,259,635 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $110.4K | 751,533 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $106.7K | 3,114,805 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $105.0K | 6,933,277 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $96.8K | 2,329,407 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $95.2K | 3,493,607 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $90.4K | 686,922 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $88.5K | 2,360,139 | 0.0% |
| Quotient LTD | SHS | G73268107 | $84.4K | 16,200,818 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $83.0K | 2,780,097 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $81.9K | 10,803,857 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $75.3K | 4,544,062 | 0.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $71.6K | 4,224,389 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $65.2K | 15,711,334 | 0.0% |